Literature DB >> 9386804

Direct ex vivo flow cytometric analysis of human microglial cell CD4 expression: examination of central nervous system biopsy specimens from HIV-seropositive patients and patients with other neurological disease.

A D Dick1, M Pell, B J Brew, E Foulcher, J D Sedgwick.   

Abstract

OBJECTIVE: To define a clear ex vivo flow cytometric phenotype for adult human microglia that would distinguish it from all other macrophage lineage cells in the central nervous system (CNS) or blood, and to utilize this phenotype to examine the activation state and CD4 expression of microglia freshly derived from CNS tissue of HIV-positive patients and those with other neurological diseases.
DESIGN: Fresh human CNS tissue from both HIV-uninfected and HIV-infected individuals was obtained by biopsy or resection, and cells isolated immediately, labelled for flow cytometry and analysed.
METHODS: A Percoll density gradient isolation technique and phenotypic characteristics used for rodent microglia were applied and modified.
RESULTS: Resident microglia could clearly be defined by the flow cytometric phenotype CD45low CD4- CD11b+ CD11chigh major histocompatibility complex (MHC) class II+ CD26- CD14-. Assuming normally low-level MHC class II expression in the healthy CNS, it was likely that MHC class II positivity reflected underlying pathology necessitating biopsy or resection and appeared to be a 'leaky' activation marker. Microglia activation was observed in specimens from only six (35%) out of 17 HIV-uninfected but all four (100%) HIV-infected patients, defined strictly as any level of upregulation of CD4 expression, to produce the phenotype CD45low/medium CD4low CD11b+ CD1.1Chigh MHC class II+/+2 CD26- CD14-. Where examined by immunohistology, CD68 was also upregulated in these cases.
CONCLUSIONS: When activated in situ, microglia express low levels of CD4 and this is always seen in tissue from HIV-infected patients. Using the flow cytometric phenotype established here, microglia from HIV-infected tissue can now be isolated in pure form and studied directly ex vivo.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9386804     DOI: 10.1097/00002030-199714000-00006

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  27 in total

Review 1.  Central nervous system myeloid cells as drug targets: current status and translational challenges.

Authors:  Knut Biber; Thomas Möller; Erik Boddeke; Marco Prinz
Journal:  Nat Rev Drug Discov       Date:  2015-12-04       Impact factor: 84.694

2.  Arginine deprivation and immune suppression in a mouse model of Alzheimer's disease.

Authors:  Matthew J Kan; Jennifer E Lee; Joan G Wilson; Angela L Everhart; Candice M Brown; Andrew N Hoofnagle; Marilyn Jansen; Michael P Vitek; Michael D Gunn; Carol A Colton
Journal:  J Neurosci       Date:  2015-04-15       Impact factor: 6.167

3.  Determinants of syncytium formation in microglia by human immunodeficiency virus type 1: role of the V1/V2 domains.

Authors:  J T Shieh; J Martín; G Baltuch; M H Malim; F González-Scarano
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

Review 4.  HIV-1 target cells in the CNS.

Authors:  Sarah B Joseph; Kathryn T Arrildt; Christa B Sturdevant; Ronald Swanstrom
Journal:  J Neurovirol       Date:  2014-09-19       Impact factor: 2.643

5.  In vivo characterization of macrophage-tropic simian immunodeficiency virus molecular clones in rhesus macaques.

Authors:  Sanjeev Gumber; Praveen Kumar Amancha; Po-Jen Yen; Francois Villinger; Dana Gabuzda; Siddappa N Byrareddy
Journal:  J Neurovirol       Date:  2018-03-28       Impact factor: 2.643

6.  CD163 identifies perivascular macrophages in normal and viral encephalitic brains and potential precursors to perivascular macrophages in blood.

Authors:  Woong-Ki Kim; Xavier Alvarez; Jeanne Fisher; Benjamin Bronfin; Susan Westmoreland; JoAnne McLaurin; Kenneth Williams
Journal:  Am J Pathol       Date:  2006-03       Impact factor: 4.307

7.  Human retinal microglia express candidate receptors for HIV-1 infection.

Authors:  V T Pham; L Wen; P McCluskey; M C Madigan; P L Penfold
Journal:  Br J Ophthalmol       Date:  2005-06       Impact factor: 4.638

8.  Curcumin Attenuates gp120-Induced Microglial Inflammation by Inhibiting Autophagy via the PI3K Pathway.

Authors:  Guiling Chen; Sisi Liu; Rui Pan; Guangming Li; Haijie Tang; Mingliang Jiang; Yanyan Xing; Fujun Jin; Liqing Lin; Jun Dong
Journal:  Cell Mol Neurobiol       Date:  2018-08-28       Impact factor: 5.046

9.  Biological analysis of human immunodeficiency virus type 1 R5 envelopes amplified from brain and lymph node tissues of AIDS patients with neuropathology reveals two distinct tropism phenotypes and identifies envelopes in the brain that confer an enhanced tropism and fusigenicity for macrophages.

Authors:  Paul J Peters; Jayanta Bhattacharya; Samantha Hibbitts; Matthias T Dittmar; Graham Simmons; Jeanne Bell; Peter Simmonds; Paul R Clapham
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

10.  Quantification of the rat spinal microglial response to peripheral nerve injury as revealed by immunohistochemical image analysis and flow cytometry.

Authors:  J Blackbeard; K P O'Dea; V C J Wallace; A Segerdahl; T Pheby; M Takata; M J Field; A S C Rice
Journal:  J Neurosci Methods       Date:  2007-05-04       Impact factor: 2.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.